Patterns of response in metastatic NSCLC during PD‐1 or PD‐L1 inhibitor therapy: Comparison of the RECIST 1.1 and iRECIST criteria

BACKGROUND: Immunotherapy plays an important role in advanced non‐small cell lung cancer (NSCLC). However, radiological evaluation is challenging due to the potential inflammatory effects of immunotherapy, which can lead to atypical response patterns. Identifying these atypical responses is critical...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Hongge, Xu, Yan, Chen, Minjiang, Zhong, Wei, Wang, Mengzhao, Zhao, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113040/
https://www.ncbi.nlm.nih.gov/pubmed/32129934
http://dx.doi.org/10.1111/1759-7714.13367

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7113040/
https://www.ncbi.nlm.nih.gov/pubmed/32129934
http://dx.doi.org/10.1111/1759-7714.13367

Ejemplares similares